British Columbia

Medical marijuana company gives $1M to UBC HIV researcher

A B.C. medical marijuana company is funding research into the potential of pot to treat HIV/AIDS and alleviate pain and nausea for patients.

Company wants more research on therapeutic effects of pot on HIV patients

A Richmond-based medical marijuana company is donating $1 million to research at UBC.

A UBC researcher is getting $1 million dollars from a medical marijuana company to fund research into pot's potential to treat HIV/AIDS and alleviate pain and nausea in patients.

M.J. Milloy, an infectious disease researcher at UBC, published a study earlier this year how daily marijuana use can help HIV positive people.

The donation comes from National Green Biomed, a Richmond, B.C., company co-founded by former Liberal MP Herb Dhaliwal.

"Because cannabis has been seen primarily as a recreational drug, its medical implications have been much overlooked in formal research circles," said Dhaliwal in a UBC press release.

The company is still awaiting a Health Canada license to cultivate marijuana at a site in the Fraser Valley, according to the release.


To encourage thoughtful and respectful conversations, first and last names will appear with each submission to CBC/Radio-Canada's online communities (except in children and youth-oriented communities). Pseudonyms will no longer be permitted.

By submitting a comment, you accept that CBC has the right to reproduce and publish that comment in whole or in part, in any manner CBC chooses. Please note that CBC does not endorse the opinions expressed in comments. Comments on this story are moderated according to our Submission Guidelines. Comments are welcome while open. We reserve the right to close comments at any time.